Dipivefrin

CHEMBL1201262 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
351.4 g/mol
LogP
2.9
Phase
4

A prodrug of epinephrine (adrenaline) used as eye drops to lower intraocular pressure in open-angle glaucoma. After penetrating the eye, it is converted to epinephrine, which reduces fluid production and increases drainage within the eye. The prodrug form penetrates the cornea more effectively than epinephrine itself.

Khối lượng phân tử

351,4000 g/mol

LogP

2,90

TPSA

84,90 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1

InChI

InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3

Molecular Formula

C19H29NO5

HBD / HBA

2 / 6

Liên kết có thể quay

9

Nguyên tử nặng

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A prodrug of epinephrine (adrenaline) used as eye drops to lower intraocular pressure in open-angle glaucoma. After penetrating the eye, it is converted to epinephrine, which reduces fluid production and increases drainage within the eye. The prodrug form penetrates the cornea more effectively than epinephrine itself.

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Yes, Dipivefrin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201262. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3105. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.